A Trial for a Personalized Medication Management Platform to Improve Medication Adherence

July 22, 2014 updated by: Taipei Medical University

Mobile Intelligent Personal Medication Management Platform

Taiwan has attracted much attention for its National Health Insurance (NHI) and healthcare system around the world with many countries in Europe and the United States using it as a benchmark. However, increasing medication costs over the past two years account for more than 25% of total expenditure, surpassing every OECD member and mounting increasing pressure on the NHI. Nevertheless, patient medication adherence is relatively low. Thus, the investigators assessed the effectiveness of a personalized medication management system for improving the medication adherence for patients, in order to save long term medication costs.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Design, Setting and Patients: The investigators developed a mobile personalized medication management platform (PMMP) to reduce delayed and missed medications. The investigators conducted a randomized control trial in medical centers of northern Taiwan from January 2010 to July 2012 using 1198 participants that missed or delayed their medications during past three days. They received a minimum 7-day to 14-day maximum medication prescription.

Interventions: Patients were randomized into a control group which non-received any SMS reminder for medication using and an intervention group which received a SMS reminder everyday in mobile devices.

Primary Outcome(s) and Measure(s): The primary outcomes were compared patient medication adherence among experimental and control groups.

Study Type

Interventional

Enrollment (Actual)

763

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Delayed or forgot to take medications over the last 3 days
  • Received a min. 7-day medication prescription
  • Able to receive SMS using mobile phones / devices
  • 20 years or older
  • Having intention to receive active treatment

Exclusion Criteria:

  • Unable to receive SMS via mobile phones
  • Illiterate and < 20 years of age
  • Received outpatient prescription drugs for ≤ 7 days
  • External use, injections and traditional Chinese medicine
  • Planned to go abroad
  • Cold, cough, or prescribed with analgesics

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: SMS Medication Reminder
763 patients were assigned to experimental group
Device: Personalized Medication Management Platform for SMS Reminder
The Personalized Medication Management Platform was developed by investigators that integrated with Hospital Information System (HIS) to collect the prescription information of patients and automatically send SMS to remind
No Intervention: No SMS Reminder
435 patients were assigned to control group as no SMS reminder

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The proportion of patients in delaying and forgetting medications
Time Frame: Patients who participated in this trial will be sent SMS during 7days
Patients who participated in this trial will be sent SMS during 7days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Taipei Medical University

Collaborators

Taipei Veterans General Hospital, Taiwan
National Science Council, Taiwan
National Yang Ming University
Taipei Medical University WanFang Hospital
National Taiwan University
National Chung Cheng University
China Medical University, Taiwan
National Tsing Hua University, HsinChu City, Taiwan
Hwa Hsia Institute of Technology, New Taipei City, Taiwan

Investigators

  • Principal Investigator: Yu-Chuan Li, MD., PhD, Taipei Medical University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2010

Primary Completion (Actual)

July 1, 2012

Study Completion (Actual)

November 1, 2012

Study Registration Dates

First Submitted

July 17, 2014

First Submitted That Met QC Criteria

July 22, 2014

First Posted (Estimate)

July 23, 2014

Study Record Updates

Last Update Posted (Estimate)

July 23, 2014

Last Update Submitted That Met QC Criteria

July 22, 2014

Last Verified

June 1, 2014

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • NSC 99-2218-E-038-001

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe